Found: 28
Select item for more details and to access through your institution.
Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 4, p. 483, doi. 10.1016/j.clgc.2023.04.008
- By:
- Publication type:
- Article
A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Versus Pembrolizumab Plus Axitinib and Versus Avelumab Plus Axitinib in First-Line Treatment of Advanced Renal Cell Carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 4, p. e1, doi. 10.1016/j.clgc.2021.01.009
- By:
- Publication type:
- Article
Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 3, p. 217, doi. 10.1016/j.clgc.2020.07.012
- By:
- Publication type:
- Article
Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5413, doi. 10.1007/s10238-023-01235-6
- By:
- Publication type:
- Article
Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1229016
- By:
- Publication type:
- Article
Evaluation of fosaprepitant-associated hypersensitivity reactions at a National Cancer Center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1369, doi. 10.1177/1078155219895312
- By:
- Publication type:
- Article
Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 10, p. 376, doi. 10.46883/2024.25921027
- By:
- Publication type:
- Article
Metastatic Renal Cell Carcinoma With Sarcomatoid Features.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 4, p. 221
- By:
- Publication type:
- Article
Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 5, p. 171, doi. 10.46883/onc.2020.3405.0171
- By:
- Publication type:
- Article
Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline Review.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 3, p. 97
- By:
- Publication type:
- Article
Upfront Chemotherapy for Metastatic Prostate Cancer.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 12, p. 956
- By:
- Publication type:
- Article
A Patient With Newly Diagnosed Metastatic Type 2 Papillary Renal Cell Carcinoma.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 11, p. 880, doi. 10.46883/onc.2015.2911.0880
- By:
- Publication type:
- Article
Collision Renal Cell Papillary and Medullary Carcinoma in a 66-Year-Old Man.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
A Rare Case of Metastatic Renal Epithelioid Angiomyolipoma.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03682-w
- By:
- Publication type:
- Article
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2961, doi. 10.1007/s00262-023-03469-5
- By:
- Publication type:
- Article
Do we need skin toxicity? Association of immune checkpoint inhibitor and tyrosine kinase inhibitor‐related cutaneous adverse events with outcomes in metastatic renal cell carcinoma.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 10, p. 1242, doi. 10.1111/ijd.15583
- By:
- Publication type:
- Article
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1920, doi. 10.3390/cancers16101920
- By:
- Publication type:
- Article
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1456, doi. 10.3390/cancers16081456
- By:
- Publication type:
- Article
Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 408, doi. 10.3390/cancers15020408
- By:
- Publication type:
- Article
Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer.
- Published in:
- Integrative Cancer Therapies, 2018, v. 17, n. 4, p. 1103, doi. 10.1177/1534735418803755
- By:
- Publication type:
- Article
Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 12, p. 3386, doi. 10.1002/cam4.919
- By:
- Publication type:
- Article
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 7, doi. 10.1007/s00280-022-04443-1
- By:
- Publication type:
- Article
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1019, doi. 10.1007/s00280-010-1252-x
- By:
- Publication type:
- Article
Patient‐reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma.
- Published in:
- BJU International, 2020, v. 126, n. 1, p. 73, doi. 10.1111/bju.15058
- By:
- Publication type:
- Article
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. 453, doi. 10.1093/oncolo/oyac048
- By:
- Publication type:
- Article
Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors.
- Published in:
- Korean Journal of Radiology, 2021, v. 22, n. 10, p. 1650, doi. 10.3348/kjr.2020.1391
- By:
- Publication type:
- Article